左侧乳腺癌放疗中DIBH资格相关变量识别及预测模型开发:一项带时间验证的前瞻性队列研究
前瞻性单机构观察性研究纳入2023年1月至2024年3月治疗的253例左侧乳腺癌女性,其中206例用于模型开发、47例用于时间验证。逻辑混合模型发现平均屏气时间延长和振幅降低与DIBH资格显著相关,年龄增加与不合格几率升高相关;验证队列AUC为80.9%(95%CI:73.0-88.8)。作者认为该模型有潜力作为决策支持工具,但需进一步外部验证后才能整合入常规临床实践。
要点
- 平均屏气时间延长(OR 0.308,95%CI 0.104-0.910,p=0.033)和振幅降低(OR 0.737,95%CI 0.641-0.848,p<0.001)是DIBH资格的显著预测因素。
- 年龄增加与DIBH不合格几率升高相关(OR 1.040,95%CI 1.001-1.081,p=0.044)。
- 模型在时间验证队列中AUC为80.9%(95%CI 73.0-88.8),作者认为需进一步外部验证后才能整合入常规临床实践。
核心结论
- 识别了与DIBH资格相关的变量并开发了预测模型,该模型有潜力作为决策支持工具,但需进一步外部验证后才能整合入常规临床实践。
研究设计与样本
- 前瞻性、单机构、经IRB批准的观察性研究,纳入2023年1月至2024年3月治疗的左侧乳腺癌女性,患者在连续2-3天内进行多次屏气 sessions,记录并分析DIBH波形指标和临床因素,采用逻辑混合模型预测DIBH资格,并使用时间验证队列评估模型性能。
主要发现
- 共纳入253例患者,模型开发队列206例,时间验证队列47例。
- 最终逻辑混合模型识别平均屏气时间延长(OR 0.308,95%CI 0.104-0.910,p=0.033)和振幅降低(OR 0.737,95%CI 0.641-0.848,p<0.001)为DIBH资格的显著预测因素。
- 年龄增加与DIBH不合格几率升高相关(OR 1.040,95%CI 1.001-1.081,p=0.044)。
- 模型在验证队列中表现出良好的区分性能,AUC为80.9%(95%CI 73.0-88.8)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步外部验证才能将模型整合入常规临床实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify variables associated with a patients' ability to reproducibly hold their breath for deep-inspiration breath-hold (DIBH) radiotherapy (RT) and to develop a predictive model for DIBH eligibility. METHODS: This prospective, single-institution, IRB-approved observational study included women with left-sided breast cancer treated between January 2023 and March 2024. Patients underwent multiple breath-hold sessions over 2-3 consecutive days. DIBH waveform metrics and clinical factors were recorded and analysed. Logistic mixed modelling was used to predict DIBH eligibility, and a temporal validation cohort was used to assess model performance. RESULTS: In total, 253 patients were included, with 206 in the model development cohort and 47 in the temporal validation cohort. The final logistic mixed model identified increasing average breath-hold duration (OR, 95% CI: 0.308, 0.104-0.910. p = 0.033) and lower amplitude (OR, 95% CI: 0.737, 0.641-0.848. p < 0.001) as significant predictors of DIBH eligibility. Increasing age was associated with higher odds of being ineligible for DIBH (OR, 95% CI: 1.040, 1.001-1.081. p = 0.044). The model demonstrated good discriminative performance in the validation cohort with an AUC of 80.9% (95% CI: 73.0-88.8). CONCLUSION: The identification of variables associated with DIBH eligibility and development of a predictive model has the potential to serve as a decision-support tool. Further external validation is required before its integration into routine clinical practice.
引用
- Ahmad I, Chufal KS, Miller AA, et al. Identification of variables and development of a prediction model for DIBH eligibility in left-sided breast cancer radiotherapy: a prospective cohort study with temporal validation. Radiat Oncol. 2024. PMID: 39210454. doi:10.1186/s13014-024-02512-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。